A computer being used for management

credit: istock.com/Khanchit Khirisutchalual

Flare Therapeutics adopts Simplicis Ledger to modernize compound management

By adopting Simplicis Ledger, Flare Therapeutics replaces manual "human-babysitting" of data with automation-ready infrastructure to scale life sciences R&D.
| 1 min read
Written byFlare Therapeutics
Register for free to listen to this article
Listen with Speechify
0:00
1:00

CAMBRIDGE, MA, 2nd March, 2026 - Simplicis, a provider of modern sample and inventory management software for life sciences, today announced that Flare Therapeutics has selected Simplicis Ledger as its primary compound and inventory management platform. The partnership marks a strategic shift for Flare Tx, moving away from fragile, person-dependent workflows toward a resilient, automated foundation for drug discovery.

As biotech teams remain lean, many organizations face "operational fragility”, where critical scientific data relies on a single individual or a web of manual workarounds. Flare Therapeutics recognized this bottleneck and chose Ledger to bridge the gap between physical inventory and digital automation.

“We reached a point where our system required more human babysitting and workarounds than I could reliably provide without help,” said Caitlin O'Brien, Compound Management Lead at Flare Therapeutics. “As the primary compound manager in the company, I needed infrastructure we could actually trust. Ledger gives us that, allowing us to scale without increasing headcount or overhead.”

Breaking the Cycle of "Offline" Data Management

Prior to this implementation, Flare Tx’s workflows, including assay-ready plate production and acoustic dispensing required significant manual oversight and custom IT workarounds. These "offline" processes created operational risks and hindered cross-training.

By implementing Ledger and Ledger Acoustic, Flare Tx has achieved:

  • End-to-End Transparency: Real-time alignment between inventory state and assay execution.
  • Automation-Ready Workflows: Seamless integration with acoustic dispensing platforms, removing the need for manual file handling.
  • Operational Continuity: A unified system that allows for predictable workflow management and easier team-wide adoption.

“Flare Tx’s move reflects a broader biotech trend: the shift from brittle, workaround-driven systems to 'Scientific Infrastructure' that supports velocity,” said James Craven, Chief Commercial Officer at Simplicis. “Ledger was designed to remove the hidden friction between inventory, automation, and people.”

For more information on how Simplicis is modernizing R&D infrastructure, visit www.simplicis.com

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular rendering of antibody proteins with blue and gold surface structures floating against a soft blue background
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Gloved hand holding a microcentrifuge tube while a pipette dispenses liquid
Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.
Illustration of a cell undergoing division, showing two connected daughter cells with visible nuclei, rendered in blue tones
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology in vitro.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue